Effects of the combination therapy of irbesartan and indapamide in chronik kidney disease with hypertension

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2013
INTERVENTION: irbesartan 100mg/day + indapamide 1mg/day CONDITION: chronick kidney disease with hypertension PRIMARY OUTCOME: The change of blood pressure, heart function, renal function INCLUSION CRITERIA: 1) >=20 years old 2)chronik kidney disease stage G1, G2, G3a,G3b,G4 3)hypertension(140/90 mmHg) irrespected of antihypertensive therapy
Epistemonikos ID: c43603f894a5db24d390bb561bfec5e8100f3656
First added on: Aug 22, 2024